Elevated LDL-C and Lipoprotein(a) Modify Alirocumab Effects on CAV

Kosei Terada, Kuniaki Takahashi, Kiran K. Khush, Takeshi Nishi, Joshua W. Knowles, Anette Skoda, Brandon Varr, Christopher Woo, Yasuhiro Honda, William F. Fearon

Open source

DOI: 10.1016/j.jchf.2026.103284
Published: 2026-08
Container: JACC: Heart Failure
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.jchf.2026.103284,
  title = {Elevated LDL-C and Lipoprotein(a) Modify Alirocumab Effects on CAV},
  author = {Kosei Terada and Kuniaki Takahashi and Kiran K. Khush and Takeshi Nishi and Joshua W. Knowles and Anette Skoda and Brandon Varr and Christopher Woo and Yasuhiro Honda and William F. Fearon},
  year = {2026},
  journal = {JACC: Heart Failure},
  doi = {10.1016/j.jchf.2026.103284},
  url = {https://doi.org/10.1016/j.jchf.2026.103284}
}

RIS

TY  - JOUR
TI  - Elevated LDL-C and Lipoprotein(a) Modify Alirocumab Effects on CAV
AU  - Kosei Terada
AU  - Kuniaki Takahashi
AU  - Kiran K. Khush
AU  - Takeshi Nishi
AU  - Joshua W. Knowles
AU  - Anette Skoda
AU  - Brandon Varr
AU  - Christopher Woo
AU  - Yasuhiro Honda
AU  - William F. Fearon
PY  - 2026
JO  - JACC: Heart Failure
DO  - 10.1016/j.jchf.2026.103284
UR  - https://doi.org/10.1016/j.jchf.2026.103284
ER  -

APA

Terada, K., Takahashi, K., Khush, K. K., Nishi, T., Knowles, J. W., Skoda, A., Varr, B., Woo, C., Honda, Y., & Fearon, W. F. (2026). Elevated LDL-C and Lipoprotein(a) Modify Alirocumab Effects on CAV. JACC: Heart Failure. https://doi.org/10.1016/j.jchf.2026.103284

Source records

crossref · retrieved 2026-09-26T23:31:14.343Z